A Missouri startup is preparing human trials of sensor technology that measures blood flow resistance in real time, potentially transforming how clinicians monitor sepsis and blood disorders without drawing samples.

Only subscribers get to read this.

Hit SUBSCRIBE for freemium or paid content access.